Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis

Journal of Immunology

Volumn 161, Issue 11, 1998, Pages 6338-6346

  Avirutnan, Panisadee ^a,b   Malasit, Prida ^b   Seliger, Barbara ^a   Bhakdi, Sucharit ^a   Husmann, Matthias ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; RANTES;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PLASMA; PLEURA FLUID; PRIORITY JOURNAL; TRANSACTIVATION;

APOPTOSIS; CELL DEATH; CELL LINE; CHEMOKINES; COMPLEMENT ACTIVATION; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-8; NF-KAPPA B; RANTES; TRANSCRIPTION, GENETIC; UMBILICAL CORD; UP-REGULATION;

EID: 0032402295     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Henchal, E. A., and J. R. Putnak. 1990. The dengue viruses. Clin. Microbiol. Rev. 3:376.
2. Thein, S., M. M. Aung, T. N. Shwe, M. Aye, A. Zaw, K. Aye, K. M. Aye, and J. Aaskov. 1997. Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56:566.
3. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395.
4. Nimmannitya, S. 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 18:392.
5. Bokisch, V. A., F. H. Top, Jr., P. K. Russell, F. J. Dixon, and H. J. Muller-Eberhard. 1973. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N. Engl. J. Med. 289:996.
6. Innis, B. L. 1995. Dengue and dengue hemorrhagic fever. In Exotic Viral Infection. J. S. Porterfield, ed. Chapman & Hall, London, p. 103.
7. Halstead, S. B. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev. Infect. Dis. 11 (Suppl. 4):S830.
8. Kurane, I., A. L. Rothman, P. G. Livingston, S. Green, S. J. Gagnon, J. Janus, B. L. Innis, S. Nimmannitya, A. Nisalak, and F. A. Ennis. 1994. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 9:59.
9. Halstead, S. B., and E. J. O'Rourke 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:201.
10. Bhakdi, S., and M. D. Kazatchkine. 1990. Pathogenesis of dengue: an alternative hypothesis. Southeast Asian J. Trop. Med. Public Health 21:652.
11. Butthep, P., A. Bunyaratvej, and N. Bhamarapravati. 1993. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 24:246.
12. Andrews, B. S., A. N. Theofilopoulos, C. J. Peters, D. J. Loskutoff, W. E. Brandt, and F. J. Dixon. 1978. Replication of dengue and Junin viruses in cultured rabbit and human endothelial cells. Infect. Immun. 20:776.
13. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. WHO, Geneva, 1986.
14. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
15. Klouche, M., S. Gottschling, V. Gerl, W. Hell, M. Husmann, B. Dorweiler, M. Meßner, and S. Bhakdi. 1998. Atherogenic properties of enzymatically degraded low density lipoprotein: selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscler. Thromb. Vasc. Biol. 18:1376.
16. Bhakdi, S., M. Muhly, S. Korom, and G. Schmidt. 1990. Effects of Escherichia coli hemolysin on human monocytes: cytocidal action and stimulation of interleukin 1 release. J. Clin. Invest. 85:1746.
17. Husmann, M., P. Jehnichen, B. Jahn, D. Schlosshan, E. Romahn, and J. Marx. 1996. A novel SP-1 site in the human interleukin-1 beta promoter confers preferential transcriptional activity in keratinocytes. Eur. J. Immunol. 26:3008.
18. Hugo, F., S. Kramer, and S. Bhakdi. 1987. Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement. J. Immunol. Methods. 99:243.
19. Cardiff, R. D., and J. K. Lund. 1976. Distribution of dengue-2 antigens by electron immunocytochemistry. Infect. Immun. 13:1699.
20. Catanzaro, P. J., W. E. Brandt, W. R. Hogrefe, and P. K. Russell. 1974. Detection of dengue cell-surface antigens by peroxidase-labeled antibodies and immune cytolysis. Infect. Immun. 10:381.
21. Ng, M. L., and L. C. Corner. 1989. Detection of some dengue-2 virus antigens in infected cells using immuno-microscopy. Arch. Virol. 104:197.
22. Gavrieli, Y., Y. Sherman, and S. A. Ben Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119:493.
23. Marianneau, P., A. Cardona, L. Edelman, V. Deubel and P. Desprès. 1997. Dengue virus replication in human hepatoma cells activates NF-κb which in turn induces apoptotic cell death. J. Virol 71:3244.
24. Baichwal, V. R., and P. A. Baeuerle. 1997. Activate NF-κB or die? Curr. Biol. 7:R9.
25. Anonymous. 1973. Pathogenetic mechanisms in dengue haemorrhagic fever: report of an international collaborative study. Bull. W. H. O. 48:117.
26. Malasit, P. 1987. Complement and dengue haemorrhagic fever/shock syndrome. Southeast Asian J. Trop. Med. Public Health 18:316.
27. Lachmann, P. J., R. G. Oldroyd, C. Milstein, and B. W. Wright. 1980. Three rat monoclonal antibodies to human C3. Immunology 41:503.
28. Lachmann, P. J., M. K. Pangburn, and R. G. Oldroyd. 1982. Breakdown of C3 after complement activation: identification of a new fragment C3g, using monoclonal antibodies. J. Exp. Med. 156:205.
29. Bhakdi, S., W. Fassbender, F. Hugo, M. P. Carreno, C. Berstecher, P. Malasit, and M. D. Kazatchkine. 1988. Relative inefficiency of terminal complement activation. J. Immunol. 141:3117.
30. Witt, D. P., and A. D. Lander. 1994. Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4:394.
31. Rot, A., E. Hub, J. Middleton, F. Pons, C. Rabeck, K. Thierer, J. Wintle, B. Wolff, M. Zsak, and P. Dukor. 1996. Some aspects of IL-8 pathophysiology. III. Chemokine interaction with endothelial cells. J. Leukocyte Biol. 59:39.
32. Erlinger, R. 1995. Glycosaminoglycans in porcine lung: an ultrastructural study using cupromeronic blue. Cell Tissue Res. 281:473.
33. Rampart, M., J. van Damme, L. Zonnekeyn, and A. G. Herman. 1989. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am. J. Pathol. 135:21.
34. Anthony, V. B., S. W. Godbey, S. L. Kunkel, J. W. Hott, D. L. Hartman, M. D. Burcick, and R. M. Stricter. 1993. Recruitment of inflammatory cells to the pleural space. J. Immunol. 12:7216.
35. Saadi, S., and J. L. Platt. 1995. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J. Exp. Med. 181:21.
36. Tuchinda, M., B. Dhorranintra, and P. Tuchinda. 1977. Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. Southeast J. Trop. Med. Public Health 8:80.
37. Platt, J. L., A. P. Dalmasso, B. J. Lindman, N. S. Ihrcke, and F. H. Bach. 1991. The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur. J. Immunol. 21:2887.
38. Chen, Y., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866.